中国医药
中國醫藥
중국의약
CHINA MEDICINE
2011年
9期
1067-1069
,共3页
俸军林%李浩%吴岚%李清华%郭萃蓉
俸軍林%李浩%吳嵐%李清華%郭萃蓉
봉군림%리호%오람%리청화%곽췌용
脑缺血%吡格列酮%环氧化酶2%脑保护作用
腦缺血%吡格列酮%環氧化酶2%腦保護作用
뇌결혈%필격렬동%배양화매2%뇌보호작용
Ischemia-reperfusion injury%Pioglitazone%Cyclooxygenase-2%Protective effect on brain
目的 探讨吡格列酮对脑缺血再灌注大鼠的脑保护作用及机制.方法 80只雄性SD大鼠完全随机分为假手术组、生理盐水组(NSP组)、小剂量吡格列酮干预组(LDPP组,吡格列酮:10 mg/kg)、大剂量吡格列酮干预组(HDPP组,吡格列酮:15 mg/kg)各20只.采用线栓法制作大鼠局灶性脑缺血再灌注模型.缺血2 h再灌注22 h后观察大鼠神经功能评分,测量脑梗死体积,用免疫组化法观察大鼠额顶部皮质环氧化酶2(COX-2)表达.结果 与NSP组比较,应用吡格列酮干预组的LDPP组和HDPP组大鼠的神经功能评分明显降低、脑梗死体积缩小[神经功能评分:(1.8±0.6)分、(1.5±0.4)分比(2.7±0.8)分,均P<0.05;脑梗死体积比:(23.4±8.8)%、(15.3±7.1)%比(37.4±9.4)%;均P<0.01].NSP组、LDPP组和HDPP组额顶叶皮质COX-2表达分别为78.7±6.7、65.6±6.1、48.7±5.1,与假手术组(脑组织中未见COX-2阳性表达)比较,NSP组额顶叶皮质COX-2表达明显增加.与NSP组比较,LDPP组和HDPP组的COX-2表达均明显减少(均P<0.05),尤其以HDPP组更明显.结论 吡格列酮对大鼠局灶性脑缺血再灌注损伤有防护作用,以大剂量组为优,其保护机制与其抑制脑组织COX-2表达、减轻脑组织炎症反应有关.
目的 探討吡格列酮對腦缺血再灌註大鼠的腦保護作用及機製.方法 80隻雄性SD大鼠完全隨機分為假手術組、生理鹽水組(NSP組)、小劑量吡格列酮榦預組(LDPP組,吡格列酮:10 mg/kg)、大劑量吡格列酮榦預組(HDPP組,吡格列酮:15 mg/kg)各20隻.採用線栓法製作大鼠跼竈性腦缺血再灌註模型.缺血2 h再灌註22 h後觀察大鼠神經功能評分,測量腦梗死體積,用免疫組化法觀察大鼠額頂部皮質環氧化酶2(COX-2)錶達.結果 與NSP組比較,應用吡格列酮榦預組的LDPP組和HDPP組大鼠的神經功能評分明顯降低、腦梗死體積縮小[神經功能評分:(1.8±0.6)分、(1.5±0.4)分比(2.7±0.8)分,均P<0.05;腦梗死體積比:(23.4±8.8)%、(15.3±7.1)%比(37.4±9.4)%;均P<0.01].NSP組、LDPP組和HDPP組額頂葉皮質COX-2錶達分彆為78.7±6.7、65.6±6.1、48.7±5.1,與假手術組(腦組織中未見COX-2暘性錶達)比較,NSP組額頂葉皮質COX-2錶達明顯增加.與NSP組比較,LDPP組和HDPP組的COX-2錶達均明顯減少(均P<0.05),尤其以HDPP組更明顯.結論 吡格列酮對大鼠跼竈性腦缺血再灌註損傷有防護作用,以大劑量組為優,其保護機製與其抑製腦組織COX-2錶達、減輕腦組織炎癥反應有關.
목적 탐토필격렬동대뇌결혈재관주대서적뇌보호작용급궤제.방법 80지웅성SD대서완전수궤분위가수술조、생리염수조(NSP조)、소제량필격렬동간예조(LDPP조,필격렬동:10 mg/kg)、대제량필격렬동간예조(HDPP조,필격렬동:15 mg/kg)각20지.채용선전법제작대서국조성뇌결혈재관주모형.결혈2 h재관주22 h후관찰대서신경공능평분,측량뇌경사체적,용면역조화법관찰대서액정부피질배양화매2(COX-2)표체.결과 여NSP조비교,응용필격렬동간예조적LDPP조화HDPP조대서적신경공능평분명현강저、뇌경사체적축소[신경공능평분:(1.8±0.6)분、(1.5±0.4)분비(2.7±0.8)분,균P<0.05;뇌경사체적비:(23.4±8.8)%、(15.3±7.1)%비(37.4±9.4)%;균P<0.01].NSP조、LDPP조화HDPP조액정협피질COX-2표체분별위78.7±6.7、65.6±6.1、48.7±5.1,여가수술조(뇌조직중미견COX-2양성표체)비교,NSP조액정협피질COX-2표체명현증가.여NSP조비교,LDPP조화HDPP조적COX-2표체균명현감소(균P<0.05),우기이HDPP조경명현.결론 필격렬동대대서국조성뇌결혈재관주손상유방호작용,이대제량조위우,기보호궤제여기억제뇌조직COX-2표체、감경뇌조직염증반응유관.
Objective To investigate the effect of different dose of pioglitazone on the expression of cyclooxygenase-2(COX-2) in focal cerebral ischemia-reperfusion injury in rats and to study the protective effect and the mechanism of pioglitazone. Methods Eighty adult male SD rats were randomly divided into four groups: sham operated group, normal sodium pretreated group(NSP group), low-dose pioglitazone pretreated group(LDPP group,10 mg/kg) and high-dose pioglitazone pretreated group(HDPP group, 15 mg/kg). Animal models of 2 h middle cerebral artery occlusion followed by 22 h reperfusion (MCAO/R) were made by suture-occluded method. After MCAO/R, we evaluated the neurological score, measured the volume of cerebral infarction, investigated the expression of COX-2 with immunohistochemistry. Results Compared with NSP group, rats in pioglitazone pretreated group(LDPP group and HDPP group), especially in HDPP group, significantly presented lower neurological score and smaller cerebral infarction volume(P < 0. 01). The expression of COX-2 of fronto-parietal lobe in NSP group were significantly increased while compared with sham operated group(P < 0.05). Compared with NSP group, the expression of COX-2 in pioglitazone pretreated group, especially in HDPP group, was significantly decreased (all P<0.05). Conclusions Pioglitazone has protective effect on focal cerebral ischemia-reperfusion injury in rats,especially in HDPP group. The protective mechanism of pioglitazone is probably related to the decreased expression of COX-2 and the improvement of inflammatory reaction in brain tissue.